Nezam H. Afdhal, Chief Medical Officer at Spring Bank Pharmaceuticals, Inc. (SBPH), bought 2,400 shares at $12.50 ($30K) on 2016-09-09, disclosed to the SEC on 2016-09-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| SBPH | BUY | 2016-08-16 | $57K | — | Filing → |
| SBPH | BUY | 2016-08-15 | $29K | — | Filing → |